Schramme, F., Crosignani, S., Frederix, K., Hoffmann, D., Pilotte, L., Stroobant, V., . . . Van Den Eynde, B. (2019). Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors. American Association for Cancer Research.
Cita Chicago (17th ed.)Schramme, F., S. Crosignani, K. Frederix, D. Hoffmann, L. Pilotte, V. Stroobant, J. Preillon, G. Driessens, i B. Van Den Eynde. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.
Cita MLA (9th ed.)Schramme, F., et al. Inhibition of Tryptophan-dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. American Association for Cancer Research, 2019.